Tokyo Joe's Cafe / Societe Anonyme/No Pennies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: majaman1978 who wrote (26981)	12/12/1998 6:58:00 PM
From: JEB	Read Replies (1) of 119973

You make good points. GNE was well funded and had a who's who list of an executive team. BGEN was a 7 1/2 stock back in 1987 (When I bought. I later had the original certificate sent to me in 1988.). They had worked in collaboration and shared research projects with several pharmaceutical and bio-tech companies. Biogen didn't have their own sole proprietary product until 1996: corporate-ir.net Look at the chart and see what a sole proprietary product can do for a stock: bigcharts.com (Note the stock split in late 1996) Before that time Biogen was another R&D lab with Royalties from license on products they helped to develop. They had warrants, preferred stock sale, ...etc. Yes, they were in the red for a while back in the 80's. Biogen (If I remember correctly) was receiving royalties from a few products when I originally bought but they did not have a sole proprietary product for quite some time. ASTM has a sole proprietary product which is about to go to market. They are not licensing this technology to another manufacturer. They are the manufacturer. They will either sell the equipment to the customer facilities or they will set up regional manufacturing facilities themselves. They can partner with other pharmaceutical firms if they wish to help offset the costs but they will receive way more in earnings from this than if they were licensing this to another manufacturer. Now PFE owns 6.4% of ASTM. edgar-online.com The State of Michigan owns 10.1% of ASTM. edgar-online.com COBE Laboratories, Inc. owns 24.2% of ASTM. edgar-online.com The Kaufmann Fund owns 19.17% of ASTM. edgar-online.com Look at the chart technicals. I see it based and ascending. The ASTM chart: bigcharts.com What I'm trying to say is this company is trading at a substantial discount (Too cheap) compared to what they should be trading at. I see a trading range of 8-12/share, short term-IMO-. 1-2 years 18-30/share range (Conservative)-IMO-. (That's barring if someone wants to buy them out) Good trading, JEB

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next